Translational Development Acquisition Corp. (TDACU) Current Assets (2023 - 2026)
Translational Development Acquisition's (TDACU) quarterly Current Assets came in at $75316.0 in Q1 2026, down 81.87% YoY from $415422.0 in Q1 2025, and up 90.84% on a QoQ basis from $39465.0 in Q4 2025.
Translational Development Acquisition Corp. (TDACU) Current Assets (2023 - 2026) Analysis & Trends
Translational Development Acquisition (TDACU) has 4 years of Current Assets data on file, last reported at $75316.0 in Q1 2026.
- Quarterly Current Assets fell 81.87% year-over-year to $75316.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $75316.0 (down 81.87% YoY) and the FY2025 annual result came in at $39465.0, down 93.93% from the prior year.
- Current Assets improved to $75316.0 in Q1 2026, from $39465.0 in the prior quarter.
- In the past five years, Current Assets ranged from a high of $650233.0 in Q4 2024 to a low of $2021.0 in Q4 2023.
- A 4-year average of $202730.9 and a median of $80582.0 in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets soared 32073.82% — and 2025, when it tumbled 93.93%.
- Tracing TDACU's Current Assets over 4 years: stood at $2021.0 in 2023, then soared by 32073.82% to $650233.0 in 2024, then plunged by 93.93% to $39465.0 in 2025, then surged by 90.84% to $75316.0 in 2026.
- The last three Current Assets figures came in at $75316.0 (Q1 2026), $39465.0 (Q4 2025), and $80582.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75,316.00 |
| Dec 31, 2025 | 39,465.00 |
| Sep 30, 2025 | 80,582.00 |
| Jun 30, 2025 | 156,077.00 |
| Mar 31, 2025 | 415,422.00 |
| Dec 31, 2024 | 650,233.00 |
| Dec 31, 2023 | 2,021.00 |